about
Cloning and characterization of RLPK, a novel RSK-related protein kinaseTransactivation of naturally occurring HIV-1 long terminal repeats by the JNK signaling pathway. The most frequent naturally occurring length polymorphism sequence introduces a novel binding site for AP-1 factorsSerine/Threonine kinases 3pK and MAPK-activated protein kinase 2 interact with the basic helix-loop-helix transcription factor E47 and repress its transcriptional activityRole of proteinase-activated receptor-2 in anti-bacterial and immunomodulatory effects of interferon-γ on human neutrophils and monocytesAgonists of proteinase-activated receptor-2 enhance IFN-gamma-inducible effects on human monocytes: role in influenza A infectionErk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4)Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathwaysThe LIM-only protein FHL2 attenuates lung inflammation during bleomycin-induced fibrosisEvidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded ProteinInfluenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade.Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling.The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcriptionNeurotrophin receptor-interacting mage homologue is an inducible inhibitor of apoptosis protein-interacting protein that augments cell deathAcetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activityRecent influenza A (H1N1) infections of pigs and turkeys in northern EuropeMrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shockMAPKAP kinase 3pK phosphorylates and regulates chromatin association of the polycomb group protein Bmi1A plant extract of Ribes nigrum folium possesses anti-influenza virus activity in vitro and in vivo by preventing virus entry to host cellsIn vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin BAvian influenza viruses inhibit the major cellular signalling integrator c-Abl.European swine virus as a possible source for the next influenza pandemic?Analysis of influenza A virus nucleoproteins for the assessment of molecular genetic mechanisms leading to new phylogenetic virus lineages.Derivation of the nucleoproteins (NP) of influenza A viruses isolated from marine mammals.CRK adaptor protein expression is required for efficient replication of avian influenza A viruses and controls JNK-mediated apoptotic responses.The Rac1 inhibitor NSC23766 exerts anti-influenza virus properties by affecting the viral polymerase complex activity.Antiviral activity of Ladania067, an extract from wild black currant leaves against influenza A virus in vitro and in vivoCYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice.Influenza, a One Health paradigm--novel therapeutic strategies to fight a zoonotic pathogen with pandemic potential.Nonstructural protein 1 (NS1)-mediated inhibition of c-Abl results in acute lung injury and priming for bacterial co-infections: insights into 1918 H1N1 pandemic?Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in influenza virionsOrigin of the 1918 pandemic H1N1 influenza A virus as studied by codon usage patterns and phylogenetic analysis.Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors.Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo.Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice.Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine.Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.Genetics, evolution, and the zoonotic capacity of European Swine influenza viruses.Previous H1N1 influenza A viruses circulating in the Mongolian population.The NF-κB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance.
P50
Q22008607-0BCA5EF7-C4E3-40E7-89A3-A666B8CD563DQ22253886-FB2993AB-B33F-48FB-9A6A-0FACD1A31E9FQ22253981-32DC5815-4DB9-4EFA-AA81-D1177A92E058Q24299943-3D0134FF-077F-4630-B601-1B3A501706D9Q24309213-05567424-B1CF-4C91-91B3-9A1CD101458BQ24321689-2E5461DF-4AD2-4091-A0AB-A1623647960FQ24522573-1B38A4EF-E691-4A2E-AABB-A0812B438597Q24647721-88F3172A-D370-4611-A9AC-F41ADBB85845Q27301282-26306E1D-8A7C-4FA4-9FDF-57D2A30CC1E8Q27319771-BA1E43D9-A82C-4549-9DDF-C521E2326780Q27863694-06D9AB7A-B203-4985-A35F-0BF5B9A0369BQ27863918-7889BF24-6EED-42A6-B281-087FC54B83D2Q28208036-5C716405-48B0-45C5-AFDD-13940EFADDDDQ28215693-F3FCB5D5-FAAD-4A0E-9B6A-7E5BE00CA4C2Q28219439-919709AF-3511-4B66-98D3-9A05D2252CBDQ28243769-C78678BE-88E2-4FD4-9915-4E582DC57EF5Q28244377-7F0105AF-52B3-48DC-9A6F-565B7372D55FQ28295095-1F19ABA2-8A89-40F2-900B-4AEA68D814AFQ28533303-8EB8B999-9B0B-4110-96E2-ACF1C182A53BQ28543407-7B5CB32C-62C3-4517-AB0C-2FC7A115DA8CQ30009343-33649282-8899-4338-98A4-AE6C280459F0Q30011195-69668A53-4D51-44E6-A1D7-ABD388DCF3EDQ30011233-C5181F35-04BE-4765-9884-B3E8642636EAQ30011264-F618BA12-4CC4-4B78-8931-DDE243FF003FQ30156990-C8472E41-9551-47D2-92BB-53C432E40DE9Q30358937-58583956-0EA8-42C7-AC59-7EDB8A4049D6Q30362204-4CF84338-DB02-4444-979D-BCFA4E632C18Q30362345-39C5D208-6955-4332-A2B5-708E48DC5455Q30366786-968061E6-1460-49F7-8E8D-6F8E91E98713Q30368379-0400DB30-F4C8-45BD-9B2B-9C7973EEBA77Q30369504-B47F22AE-DB3A-4234-A498-67EC38B3CA39Q30396106-AFE5D8B6-3BC4-4643-9343-5E4409B1E110Q30398844-1D170E86-6624-437F-82A8-9864B34BCD61Q30406177-28EFE7E6-4680-41EA-A2D0-2345EBBB1B9FQ30409773-ABEC84E0-29B5-4A1F-AD80-86C9A369D934Q30416631-44ECF7D3-EE83-431B-A5B4-47951454BD1AQ30417228-DA47B60D-C9BD-48FE-A607-DECBF4ADA7ECQ30421632-1F1B5A5A-EA50-4D9C-8C49-94848C6E8838Q30425481-993F0E22-9E18-466A-8163-5135F3E86222Q30425939-45942FB8-E9B0-4235-B093-699B9BCE8A2E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stephan Ludwig
@ast
Stephan Ludwig
@en
Stephan Ludwig
@es
Stephan Ludwig
@nl
Stephan Ludwig
@sl
type
label
Stephan Ludwig
@ast
Stephan Ludwig
@en
Stephan Ludwig
@es
Stephan Ludwig
@nl
Stephan Ludwig
@sl
prefLabel
Stephan Ludwig
@ast
Stephan Ludwig
@en
Stephan Ludwig
@es
Stephan Ludwig
@nl
Stephan Ludwig
@sl
P106
P1153
7102479985
P21
P2798
P31
P496
0000-0003-4490-3052